Streptomycin

ID: ALA1201194

Chembl Id: CHEMBL1201194

Cas Number: 1217442-17-5

PubChem CID: 6602485

Max Phase: Preclinical

Molecular Formula: C21H39N7O12

Molecular Weight: 581.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,21+/m0/s1

Standard InChI Key:  UCSJYZPVAKXKNQ-ZCTIVXDHSA-N

Associated Targets(Human)

THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
microRNA 21 (64692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium intracellulare (1532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhi (4293 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella paratyphi (588 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecalis (29875 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus flavus (568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Listeria monocytogenes (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus cereus (7522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus intermedius (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella aerogenes (4963 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptomyces scabiei (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacteroides abscessus (2066 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium fortuitum (1335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacteroides chelonae (540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium phlei (631 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium smegmatis (8003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Campylobacter coli (196 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus vulgaris (5823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus anthracis (2936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pyogenes (16140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia alcalifaciens (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enterica (1497 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella sonnei (625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Yersinia pseudotuberculosis (544 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vibrio cholerae (1211 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 581.58Molecular Weight (Monoisotopic): 581.2657AlogP: -8.16#Rotatable Bonds: 9
Polar Surface Area: 336.43Molecular Species: BASEHBA: 15HBD: 12
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.23CX Basic pKa: 10.07CX LogP: -7.06CX LogD: -11.79
Aromatic Rings: 0Heavy Atoms: 40QED Weighted: 0.07Np Likeness Score: 1.77

References

1. Li TX, Yang MH, Wang XB, Wang Y, Kong LY..  (2015)  Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.,  78  (11): [PMID:26577190] [10.1021/acs.jnatprod.5b00008]
2. Tantry SJ, Shinde V, Balakrishnan G, Markad SD, Gupta AK, Bhat J, Narayan A, Raichurkar A, Jena LK, Sharma S, Kumar N, Nanduri R, Bharath S, Reddy J, Panduga V, Prabhakar KR, Kandaswamy K, Kaur P, Dinesh N, Guptha S, Saralaya R, Panda M, Rudrapatna S, Mallya M, Rubin H, Yano T, Mdluili K, Cooper CB, Balasubramanian V, Sambandamurthy VK, Ramachandran V, Shandil R, Kavanagh S, Narayanan S, Iyer P, Mukherjee K, Hosagrahara VP, Solapure S, Hameed P S, Ravishankar S.  (2016)  Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway,  (5): [10.1039/C5MD00589B]
3. Krishnaiah M, de Almeida NR, Udumula V, Song Z, Chhonker YS, Abdelmoaty MM, do Nascimento VA, Murry DJ, Conda-Sheridan M..  (2018)  Synthesis, biological evaluation, and metabolic stability of phenazine derivatives as antibacterial agents.,  143  [PMID:29227933] [10.1016/j.ejmech.2017.11.026]
4. Fang W, Wang J, Wang J, Shi L, Li K, Lin X, Min Y, Yang B, Tang L, Liu Y, Zhou X..  (2018)  Cytotoxic and Antibacterial Eremophilane Sesquiterpenes from the Marine-Derived Fungus Cochliobolus lunatus SCSIO41401.,  81  (6): [PMID:29786436] [10.1021/acs.jnatprod.8b00015]
5. Nasrin S, Ganji S, Kakirde KS, Jacob MR, Wang M, Ravu RR, Cobine PA, Khan IA, Wu CC, Mead DA, Li XC, Liles MR..  (2018)  Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.,  81  (6): [PMID:29897754] [10.1021/acs.jnatprod.7b00903]
6. Dayakar C, Kumar BS, Sneha G, Sagarika G, Meghana K, Ramakrishna S, Prakasham RS, China Raju B..  (2017)  Synthesis, pharmacological activities and molecular docking studies of pyrazolyltriazoles as anti-bacterial and anti-inflammatory agents.,  25  (20): [PMID:28927905] [10.1016/j.bmc.2017.08.042]
7. Faria JV, Vegi PF, Miguita AGC, Dos Santos MS, Boechat N, Bernardino AMR..  (2017)  Recently reported biological activities of pyrazole compounds.,  25  (21): [PMID:28988624] [10.1016/j.bmc.2017.09.035]
8. Kwon J, Mistry T, Ren J, Johnson ME, Mehboob S..  (2018)  A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.,  26  (1): [PMID:29162308] [10.1016/j.bmc.2017.11.018]
9. Wiese J, Abdelmohsen UR, Motiei A, Humeida UH, Imhoff JF..  (2018)  Bacicyclin, a new antibacterial cyclic hexapeptide from Bacillus sp. strain BC028 isolated from Mytilus edulis.,  28  (4): [PMID:29422389] [10.1016/j.bmcl.2018.01.062]
10. Srivastava S, Bimal D, Bohra K, Singh B, Ponnan P, Jain R, Varma-Basil M, Maity J, Thirumal M, Prasad AK..  (2018)  Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.,  150  [PMID:29529504] [10.1016/j.ejmech.2018.02.067]
11. Fan YL, Jin XH, Huang ZP, Yu HF, Zeng ZG, Gao T, Feng LS..  (2018)  Recent advances of imidazole-containing derivatives as anti-tubercular agents.,  150  [PMID:29544148] [10.1016/j.ejmech.2018.03.016]
12. Garrison AT, Abouelhassan Y, Kallifidas D, Tan H, Kim YS, Jin S, Luesch H, Huigens RW..  (2018)  An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.,  61  (9): [PMID:29638121] [10.1021/acs.jmedchem.7b01903]
13. Chaturvedi AK, Verma AK, Thakur JP, Roy S, Bhushan Tripathi S, Kumar BS, Khwaja S, Sachan NK, Sharma A, Chanda D, Shanker K, Saikia D, Negi AS..  (2018)  A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity.,  26  (15): [PMID:30097361] [10.1016/j.bmc.2018.07.049]
14. Fesatidou M, Zagaliotis P, Camoutsis C, Petrou A, Eleftheriou P, Tratrat C, Haroun M, Geronikaki A, Ciric A, Sokovic M..  (2018)  5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation.,  26  (16): [PMID:30107969] [10.1016/j.bmc.2018.08.004]
15. Incerti M, Vicini P, Geronikaki A, Eleftheriou P, Tsagkadouras A, Zoumpoulakis P, Fotakis C, Ćirić A, Glamočlija J, Soković M..  (2017)  New N-(2-phenyl-4-oxo-1,3-thiazolidin-3-yl)-1,2-benzothiazole-3-carboxamides and acetamides as antimicrobial agents.,  (11): [PMID:30108732] [10.1039/C7MD00334J]
16. Rather MA, Lone AM, Teli B, Bhat ZS, Singh P, Maqbool M, Shairgojray BA, Dar MJ, Amin S, Yousuf SK, Bhat BA, Ahmad Z..  (2017)  The synthesis, biological evaluation and structure-activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents.,  (11): [PMID:30108731] [10.1039/C7MD00350A]
17. Victor K, Boris L, Athina G, Anthi P, Marija S, Marina K, Oliver R, Marina S..  (2018)  Design, synthesis and antimicrobial activity of usnic acid derivatives.,  (5): [PMID:30108976] [10.1039/C8MD00076J]
18. Lu X, Hu X, Liu Z, Zhang T, Wang R, Wan B, Franzblau SG, You Q..  (2017)  Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant Mycobacterium tuberculosis.,  (6): [PMID:30108841] [10.1039/C7MD00146K]
19. Bhat ZS, Ul Lah H, Rather MA, Maqbool M, Ara T, Ahmad Z, Yousuf SK..  (2018)  Synthesis and in vitro evaluation of substituted 3-cinnamoyl-4-hydroxy-pyran-2-one (CHP) in pursuit of new potential antituberculosis agents.,  (1): [PMID:30108910] [10.1039/C7MD00366H]
20. Marepu N, Yeturu S, Pal M..  (2018)  1,2,3-Triazole fused with pyridine/pyrimidine as new template for antimicrobial agents: Regioselective synthesis and identification of potent N-heteroarenes.,  28  (20): [PMID:30243590] [10.1016/j.bmcl.2018.09.021]
21. Cadelis MM, Pike EIW, Kang W, Wu Z, Bourguet-Kondracki ML, Blanchet M, Vidal N, Brunel JM, Copp BR..  (2019)  Exploration of the antibiotic potentiating activity of indolglyoxylpolyamines.,  183  [PMID:31550659] [10.1016/j.ejmech.2019.111708]
22. Xu Z, Zhao S, Lv Z, Feng L, Wang Y, Zhang F, Bai L, Deng J..  (2019)  Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.,  162  [PMID:30448416] [10.1016/j.ejmech.2018.11.025]
23. Brumley D, Spencer KA, Gunasekera SP, Sauvage T, Biggs J, Paul VJ, Luesch H..  (2018)  Isolation and Characterization of Anaephenes A-C, Alkylphenols from a Filamentous Cyanobacterium ( Hormoscilla sp., Oscillatoriales).,  81  (12): [PMID:30489078] [10.1021/acs.jnatprod.8b00650]
24. Stanković J, Gođevac D, Tešević V, Dajić-Stevanović Z, Ćirić A, Soković M, Novaković M..  (2019)  Antibacterial and Antibiofilm Activity of Flavonoid and Saponin Derivatives from Atriplex tatarica against Pseudomonas aeruginosa.,  82  (6): [PMID:31181926] [10.1021/acs.jnatprod.8b00970]
25. Gao C, Chang L, Xu Z, Yan XF, Ding C, Zhao F, Wu X, Feng LS..  (2019)  Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.,  163  [PMID:30530192] [10.1016/j.ejmech.2018.12.001]
26. Wang WX, Kusari S, Laatsch H, Golz C, Kusari P, Strohmann C, Kayser O, Spiteller M..  (2016)  Antibacterial Azaphilones from an Endophytic Fungus, Colletotrichum sp. BS4.,  79  (4): [PMID:26905687] [10.1021/acs.jnatprod.5b00436]
27. Liang ZM, Wang XH, Huang LR, Li QJ, Guan TQ, Hao XJ, Luo H, Yang XS..  (2016)  1α,2α-Epoxy-3β-hydroxy oleanolic acid derivatives regulation of the metabolism, haemolysis and β-lactamase gene expression in vitro and their structure-microbicidal activity relationship.,  26  (16): [PMID:27436581] [10.1016/j.bmcl.2016.07.020]
28. Parthasarathy K, Praveen C, Jeyaveeran JC, Prince AA..  (2016)  Gold catalyzed double condensation reaction: Synthesis, antimicrobial and cytotoxicity of spirooxindole derivatives.,  26  (17): [PMID:27476145] [10.1016/j.bmcl.2016.07.036]
29. Anand A, Kulkarni MV, Joshi SD, Dixit SR..  (2016)  One pot Click chemistry: A three component reaction for the synthesis of 2-mercaptobenzimidazole linked coumarinyl triazoles as anti-tubercular agents.,  26  (19): [PMID:27595420] [10.1016/j.bmcl.2016.08.045]
30. Huang LR, Hao XJ, Li QJ, Wang DP, Zhang JX, Luo H, Yang XS..  (2016)  18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.,  79  (4): [PMID:26928299] [10.1021/acs.jnatprod.5b00641]
31. Rana P, Will Y, Nadanaciva S, Jones LH..  (2016)  Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.,  26  (16): [PMID:27397500] [10.1016/j.bmcl.2016.06.088]
32. Veeravarapu H,Tirumalasetty M,Kurati S,Wunnava U,Krishna Kumar Muthyala M.  (2020)  Design, synthesis, antimycobacterial activity and molecular docking studies of novel 3- (N-substituted glycinamido) benzoic acid analogues as anti tubercular agents.,  30  (23.0): [PMID:33039564] [10.1016/j.bmcl.2020.127603]
33. Chang JL,Xu HZ,Zhou J,Zhou M,Zhang X,Guo Y,Ruan HL.  (2020)  Antimicrobial Furancarboxylic Acids from a Penicillium sp.,  83  (12): [PMID:33314934] [10.1021/acs.jnatprod.0c00758]
34. Szulczyk D,Bielenica A,Głogowska A,Augustynowicz-Kopeć E,Dobrowolski M,Roszkowski P,Stępień K,Chrzanowska A,Struga M.  (2020)  Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents.,  186  [PMID:31753514] [10.1016/j.ejmech.2019.111882]
35. Trotsko N,Golus J,Kazimierczak P,Paneth A,Przekora A,Ginalska G,Wujec M.  (2020)  Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituents.,  189  [PMID:31951961] [10.1016/j.ejmech.2020.112045]
36. Haroun M,Tratrat C,Petrou A,Geronikaki A,Ivanov M,Ciric A,Sokovic M.  (2021)  2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies.,  32  [PMID:33253880] [10.1016/j.bmcl.2020.127718]
37. Zhang B.  (2019)  Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.,  168  [PMID:30826511] [10.1016/j.ejmech.2019.02.055]
38. Bhirud JD,Patil RD,Narkhede HP.  (2020)  Sulfamic acid catalyzed synthesis of new 3,5-[(sub)phenyl]-1H-pyrazole bearing N-isonicotinoyl: And their pharmacological activity evaluation.,  30  (23): [PMID:32961321] [10.1016/j.bmcl.2020.127558]
39. Cordeiro R,Kachroo M.  (2020)  Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.,  30  (24): [PMID:33130292] [10.1016/j.bmcl.2020.127655]
40. Li D,Liu C,Jiang X,Lin Y,Zhang J,Li Y,You X,Jiang W,Chen M,Xu Y,Si S.  (2021)  Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB.,  209  [PMID:33069433] [10.1016/j.ejmech.2020.112898]
41. Malasala S,Ahmad MN,Akunuri R,Shukla M,Kaul G,Dasgupta A,Madhavi YV,Chopra S,Nanduri S.  (2021)  Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.,  212  [PMID:33190958] [10.1016/j.ejmech.2020.112996]
42. Ghosh, Arpita, Degyatoreva, Natalya, Kukielski, Casey, Story, Sandra, Bhaduri, Sayantan, Maiti, Krishnagopal, Nahar, Smita, Ray, Arjun, Arya, Dev P., Maiti, Souvik.  (2018)  Targeting miRNA by tunable small molecule binders: peptidic aminosugar mediated interference in miR-21 biogenesis reverts epithelial to mesenchymal transition,  (7.0): [PMID:30109002] [10.1039/c8md00092a]
43. Verma SK,Verma R,Verma S,Vaishnav Y,Tiwari SP,Rakesh KP.  (2021)  Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review.,  209  [PMID:33032083] [10.1016/j.ejmech.2020.112886]
44. Li B,Shen Y,Wu H,Wu X,Yuan L,Ji Q.  (2020)  Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents.,  195  [PMID:32283299] [10.1016/j.ejmech.2020.112278]
45. Gampe C, Verma VA..  (2020)  Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.,  63  (23.0): [PMID:32916044] [10.1021/acs.jmedchem.0c01177]
46. Trotsko N..  (2021)  Antitubercular properties of thiazolidin-4-ones - A review.,  215  [PMID:33588179] [10.1016/j.ejmech.2021.113266]
47. Patel KD, Mohid SA, Dutta A, Arichthota S, Bhunia A, Haldar D, Sarojini V..  (2021)  Synthesis and antibacterial study of cell-penetrating peptide conjugated trifluoroacetyl and thioacetyl lysine modified peptides.,  219  [PMID:33892275] [10.1016/j.ejmech.2021.113447]
48. Sadorn K, Saepua S, Boonyuen N, Choowong W, Rachtawee P, Pittayakhajonwut P..  (2021)  Bioactive Dimeric Tetrahydroxanthones with 2,2'- and 4,4'-Axial Linkages from the Entomopathogenic Fungus Aschersonia confluens.,  84  (4.0): [PMID:33852304] [10.1021/acs.jnatprod.0c01212]
49. Sahoo SK, Rani B, Gaikwad NB, Ahmad MN, Kaul G, Shukla M, Nanduri S, Dasgupta A, Chopra S, Yaddanapudi VM..  (2021)  Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.,  222  [PMID:34116324] [10.1016/j.ejmech.2021.113580]
50. Gou S, Li B, Ouyang X, Ba Z, Zhong C, Zhang T, Chang L, Zhu Y, Zhang J, Zhu N, Zhang Y, Liu H, Ni J..  (2021)  Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.,  64  (15.0): [PMID:34180670] [10.1021/acs.jmedchem.1c00614]
51. Knowles SL, Roberts CD, Augustinović M, Flores-Bocanegra L, Raja HA, Heath-Borrero KN, Burdette JE, Falkinham Iii JO, Pearce CJ, Oberlies NH..  (2021)  Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.,  84  (4.0): [PMID:33764773] [10.1021/acs.jnatprod.0c01309]
52. Waziri I, Isa MA, Sonopo M, Williams DBG, Muller A..  (2021)  Synthesis, anti-microbial, toxicity and molecular docking studies of N-nitroso-N-phenylhydroxylamine (cupferron) and its derivatives.,  52  [PMID:34571137] [10.1016/j.bmcl.2021.128381]
53. Hawkins PME, Hoi DM, Cheung CY, Wang T, Quan D, Sasi VM, Liu DY, Linington RG, Jackson CJ, Oehlers SH, Cook GM, Britton WJ, Clausen T, Payne RJ..  (2022)  Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin A.,  65  (6.0): [PMID:35293761] [10.1021/acs.jmedchem.1c02122]
54. Sahoo SK, Ahmad MN, Kaul G, Nanduri S, Dasgupta A, Chopra S, Yaddanapudi VM..  (2022)  Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.,  13  (5.0): [PMID:35694687] [10.1039/d1md00387a]
55. Xi XX, Hei YY, Guo Y, Zhao HY, Xin M, Lu S, Jiang C, Zhang SQ..  (2022)  Identification of benzamides derivatives of norfloxacin as promising microRNA-21 inhibitors via repressing its transcription.,  66  [PMID:35561631] [10.1016/j.bmc.2022.116803]
56. G AC, Gondru R, Li Y, Banothu J..  (2022)  Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.,  227  [PMID:34715585] [10.1016/j.ejmech.2021.113921]
57. Guo Y, Yang Y, Xu X, Li L, Zhou Y, Jia G, Wei L, Yu Q, Wang J..  (2022)  Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.,  231  [PMID:35101651] [10.1016/j.ejmech.2022.114108]
58. Deka B, Suri M, Sarma S, Devi MV, Bora A, Sen T, Dihingia A, Pahari P, Singh AK..  (2022)  Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.,  54  [PMID:34953341] [10.1016/j.bmc.2021.116580]
59. Kumar Sahoo S, Maddipatla S, Nageswara Rao Gajula S, Naiyaz Ahmad M, Kaul G, Nanduri S, Sonti R, Dasgupta A, Chopra S, Madhavi Yaddanapudi V..  (2022)  Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.,  64  [PMID:35487101] [10.1016/j.bmc.2022.116777]
60. Yang H, Kundra S, Chojnacki M, Liu K, Fuse MA, Abouelhassan Y, Kallifidas D, Zhang P, Huang G, Jin S, Ding Y, Luesch H, Rohde KH, Dunman PM, Lemos JA, Huigens RW..  (2021)  A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents.,  64  (11.0): [PMID:33881312] [10.1021/acs.jmedchem.1c00168]
61. Qin R, Wang P, Wang B, Fu L, Batt SM, Besra GS, Wu C, Wang Y, Huang H, Lu Y, Li G..  (2022)  Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.,  231  [PMID:35101648] [10.1016/j.ejmech.2022.114145]
62. Sharma A, Agrahari AK, Rajkhowa S, Tiwari VK..  (2022)  Emerging impact of triazoles as anti-tubercular agent.,  238  [PMID:35597009] [10.1016/j.ejmech.2022.114454]
63. Qin HL, Zhang ZW, Ravindar L, Rakesh KP..  (2020)  Antibacterial activities with the structure-activity relationship of coumarin derivatives.,  207  [PMID:32971428] [10.1016/j.ejmech.2020.112832]
64. Yuan Y, Jin W, Nazir Y, Fercher C, Blaskovich MAT, Cooper MA, Barnard RT, Ziora ZM..  (2020)  Tyrosinase inhibitors as potential antibacterial agents.,  187  [PMID:31810785] [10.1016/j.ejmech.2019.111892]
65. Van Meter EN, Onyango JA, Teske KA..  (2020)  A review of currently identified small molecule modulators of microRNA function.,  188  [PMID:31931338] [10.1016/j.ejmech.2019.112008]
66. Verma SK, Verma R, Kumar KSS, Banjare L, Shaik AB, Bhandare RR, Rakesh KP, Rangappa KS..  (2021)  A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies.,  219  [PMID:33878562] [10.1016/j.ejmech.2021.113442]
67. Elattar KM, El-Khateeb AY, Hamed SE..  (2022)  Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs.,  13  (5.0): [PMID:35694689] [10.1039/d2md00076h]
68. Hammouda MM, Gaffer HE, Elattar KM..  (2022)  Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a]pyrimidine scaffold.,  13  (10.0): [PMID:36325400] [10.1039/d2md00192f]
69. Cha W, Fan R, Miao Y, Zhou Y, Qin C, Shan X, Wan X, Cui T..  (2018)  MicroRNAs as novel endogenous targets for regulation and therapeutic treatments.,  (3.0): [PMID:30108932] [10.1039/C7MD00285H]
70. Ahmad S, Alam O, Naim MJ, Shaquiquzzaman M, Alam MM, Iqbal M..  (2018)  Pyrrole: An insight into recent pharmacological advances with structure activity relationship.,  157  [PMID:30119011] [10.1016/j.ejmech.2018.08.002]
71. Tomczyk MD, Walczak KZ..  (2018)  l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.,  159  [PMID:30312931] [10.1016/j.ejmech.2018.09.055]
72. Sharma A, De Rosa M, Singla N, Singh G, Barnwal RP, Pandey A..  (2021)  Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.,  64  (8.0): [PMID:33826327] [10.1021/acs.jmedchem.0c01833]
73. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK..  (2017)  Drug development against tuberculosis: Impact of alkaloids.,  137  [PMID:28628823] [10.1016/j.ejmech.2017.06.005]
74. Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V..  (2020)  Recent advancements in the development of bioactive pyrazoline derivatives.,  205  [PMID:32795767] [10.1016/j.ejmech.2020.112666]

Source